Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

28Aug 2024

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

More
07Aug 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

More

Financial Calendar

05Sep 2024

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

Add to Calendar
07Aug 2024

Amphastar Second Quarter Earnings Call

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.
Youtube